1-20 of 25
Robert Marcus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials

Clinical Trials & Observations
Carla Casulo, Jesse G. Dixon, Jennifer Le-Rademacher, Eva Hoster, Howard S. Hochster, Wolfgang Hiddemann, Robert Marcus, Eva Kimby, Michael Herold, Catherine Sebban, Emmanuel Gyan, Kenneth Foon, Tina Nielsen, Umberto Vitolo, Gilles A. Salles, Qian Shi, Christopher R. Flowers
Journal: Blood
Blood (2022) 139 (11): 1684–1693.
https://doi.org/10.1182/blood.2020010263
Published: 2022
Includes: Supplemental data
Journal Articles

An EZH2 Gene Expression Signature Is Predictive of Differential Efficacy of Chemotherapy Irrespective of EZH2 Mutation Status in Patients with Follicular Lymphoma Treated within the Gallium Trial

Verena Passerini, Vindi Jurinovic, Christopher R Bolen, Andrea Knapp, Alessia Bottos, Julia Richter, Jude Fitzgibbon, Wolfram Klapper, Andrew Davies, Robert Marcus, Michael von Bergwelt, Tina Nielsen, Martin H. Dreyling, Wolfgang Hiddemann, Michael Unterhalt, Eva Hoster, Oliver Weigert
Journal: Blood
Blood (2021) 138 (Supplement 1): 39.
https://doi.org/10.1182/blood-2021-147751
Published: 2021
Journal Articles

Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma

Clinical Trials & Observations
Christopher R. Bolen, Federico Mattiello, Michael Herold, Wolfgang Hiddemann, Sarah Huet, Wolfram Klapper, Robert Marcus, Farheen Mir, Gilles Salles, Oliver Weigert, Tina Nielsen, Mikkel Z. Oestergaard, Jeffrey M. Venstrom
Journal: Blood
Blood (2021) 137 (19): 2704–2707.
https://doi.org/10.1182/blood.2020008119
Published: 2021
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Initial Results of the MAGNOLIA (BGB-3111-214) Trial

Stephen Opat, FRACP, FRCPA, MBBS, Alessandra Tedeschi, MD, Kim Linton, MBChB, MRCP, PhD, Pamela McKay, MBChB (Hons), FRCP, FRCPath, Bei Hu, MD, Henry Chan, MBChB, FRACP, FRCPA, Jie Jin, MD PhD, Pier Luigi Zinzani, MD, Peter Browett, BMedSci, MBChB, FRACP, FRCPA, Morton Coleman, MD, Magdalena Sobieraj-Teague, MBBS, FRACP, FRCPA, M.Sc, Xiaoyan Ke, MD PhD, Mingyuan Sun, MD, Robert Marcus, MA, FRCP, FRCPath, Craig A. Portell, MD, Keshu Zhou, MD PhD, Catherine Thieblemont, MD PhD, Melannie Co, MD, Weige Wang, MD, Chris Tankersley, BS, Wenxiao Zhou, M.Sc, Massimo Cappellini, BS, Jane Huang, MD, Judith Trotman, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–30.
https://doi.org/10.1182/blood-2020-134611
Published: 2020
Journal Articles

Recil 2017 Criteria Demonstrated Similar Prognostic Value and Detected a Comparable Treatment Difference between Obinutuzumab- and Rituximab-Chemotherapy Compared with Cheson 2007 and Lugano 2014 Criteria in Patients with Previously Untreated Advanced-Stage Follicular Lymphoma

Lale Kostakoglu, MD MPH, Andrew Davies, MD PhD, Michael Herold, Wolfgang Hiddemann, Robert Marcus, Judith Trotman, FRACP, Andrea Knapp, Federico Mattiello, Tina G Nielsen, Deniz Sahin, Carol Ward, Anas Younes
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-134784
Published: 2020
Journal Articles

Phase 2 Study of Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Marginal Zone Lymphoma

Stephen Opat, Robert Marcus, MA, FRCP, FRCPath, Craig A. Portell, MD, William Reed, MD, Chris Tankersley, Jane Huang, MD, Judith Trotman, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5256.
https://doi.org/10.1182/blood-2019-122629
Published: 2019
Journal Articles

A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group

Caglar Caglayan, MS,PhD, Jesse Dixon, Statistician, MS, Anna Wall, Statistician, Gilles A. Salles, MD PhD, Eva Hoster, PhD, Wolfgang Hiddemann, MD PhD, Michael Herold, MD, Franck Morschhauser, MD PhD, Catherine Sebban, MD, Anton Hagenbeek, MD PhD, Robert Marcus, MD, Howard Hochster, MD, Mathias J Rummel, MD PhD, Eva Kimby, MD PhD, Umberto Vitolo, Bruce A. Peterson, MD, Emmanuel Gyan, MD PhD, Marco Ladetto, MD, Charles Yves Foussard, MD, Michele Ghielmini, MD, Tina G Nielsen, MD PhD, Kenneth Foon, MD, Qian Shi, PhD, Christopher R. Flowers, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2812.
https://doi.org/10.1182/blood-2019-122328
Published: 2019
Journal Articles

Obinutuzumab-Based Immunochemotherapy Prolongs Progression-Free Survival and Time to Next Anti-Lymphoma Treatment in Patients with Previously Untreated Follicular Lymphoma: Four-Year Results from the Phase III GALLIUM Study

William Townsend, MRCP,MDFRCPath, Christian Buske, MD, Guillaume Cartron, David Cunningham, Martin JS Dyer, John G. Gribben, Georg Hess, Takayuki Ishikawa, Ulrich Keller, Michael Kneba, Ram Malladi, Jeffrey D Neidhart, Chiara Rusconi, Jun Zhu, Olivier Catalani, Andrea Knapp, Harald Zeuner, Michael Herold, Wolfgang Hiddemann, Robert Marcus
Journal: Blood
Blood (2018) 132 (Supplement 1): 1597.
https://doi.org/10.1182/blood-2018-99-115167
Published: 2018
Journal Articles

Bone Marrow Biopsy Impacts Response Assessment in a Minority of Patients with Follicular Lymphoma and Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy: Results from the Randomized Phase III GALLIUM and GOYA Trials

Sarah C. Rutherford, Michael Herold, Wolfgang Hiddemann, Lale Kostakoglu, Robert Marcus, Maurizio Martelli, Laurie H Sehn, MDMPH, Marek Trněný, Judith Trotman, Umberto Vitolo, Tina Nielsen, Federico Mattiello, Deniz Sahin, Gila Sellam, Peter Martin, FRCPC, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1605.
https://doi.org/10.1182/blood-2018-99-114913
Published: 2018
Journal Articles

Minimal Residual Disease Response at End of Induction and during Maintenance Correlates with Updated Outcome in the Phase III GALLIUM Study of Obinutuzumab- or Rituximab-Based Immunochemotherapy in Previously Untreated Follicular Lymphoma Patients

Christiane Pott, Eva Hoster, Britta Kehden, Michael Unterhalt, Michael Herold, Richard van der Jagt, Ann Janssens, Michael Kneba, Jiri Mayer, MD, Christopher Pocock, MD PhD, Andrea Knapp, Nathalie Danesi, Tina Nielsen, Helen Brown, Kirsten Mundt, Robert Marcus, Wolfgang Hiddemann
Journal: Blood
Blood (2018) 132 (Supplement 1): 396.
https://doi.org/10.1182/blood-2018-99-115930
Published: 2018
Journal Articles

Matching Adjusted Indirect Comparison to Assess the Relative Efficacy of Idelalisib in Double-Refractory Follicular Lymphoma

Nishanthan Rajakumaraswamy, MBBS, MRCP, FRCA, Eleonora Lovato, MSc, Harry Smith, BSc (Hons), Timothy Bagguley, MSc, Alexandra Smith, PhD, Russell Patmore, FRCPath, Robert Marcus, MB FRCP FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 5842.
https://doi.org/10.1182/blood-2018-99-114473
Published: 2018
Journal Articles

Baseline PET-Derived Metabolic Tumor Volume Metrics Did Not Predict Outcomes in Follicular Lymphoma Patients Treated with First-Line Immunochemotherapy and Antibody Maintenance in the Phase III GALLIUM Study

Sally F Barrington, Judith Trotman, Deniz Sahin, David Belada, Andrew Davies, Robert MacEwan, Carolyn Owen, Václav Ptáčník, András Rosta, Wolfgang Hiddemann, Robert Marcus, Tina Nielsen, Federico Mattiello, Harald Zeuner, Michel Meignan
Journal: Blood
Blood (2018) 132 (Supplement 1): 2882.
https://doi.org/10.1182/blood-2018-99-117235
Published: 2018
Journal Articles

A Novel Prognostic Model That Is Superior to FLIPI-1 and FLIPI-2 and Integrates Clinical and Treatment Factors to Predict Progression-Free Survival and Early Treatment Failure in Patients with Follicular Lymphoma in the GALLIUM Trial

Farheen Mir, MBBS, Andrew Grigg, Michael Herold, Wolfgang Hiddemann, Robert Marcus, John F. Seymour, MBBS, PhD, Christopher R Bolen, Andrea Knapp, Aino Launonen, Federico Mattiello, Tina Nielsen, Mikkel Z Oestergaard, Michael Wenger, Carla Casulo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2872.
https://doi.org/10.1182/blood-2018-99-114620
Published: 2018
Journal Articles

Influence of Baseline Disease Characteristics and Exposure to Obinutuzumab on Clinical Outcome in Patients with Previously Untreated Advanced Follicular Lymphoma Treated with Obinutuzumab-Based Immunochemotherapy in the GALLIUM Trial

Candice Jamois, Ekaterina Gibiansky, Leonid Gibiansky, Vincent Buchheit, Pauline Baumlin, Denis Sahin, Guillaume Cartron, Robert Marcus, Wolfgang Hiddemann, MD PhD, John F Seymour, MBBS, PhD, Jonathan C Strefford, PhD, Georgina Meneses-Lorente, Nicolas Frey, Günter Fingerle-Rowson
Journal: Blood
Blood (2017) 130 (Supplement 1): 3848.
https://doi.org/10.1182/blood.V130.Suppl_1.3848.3848
Published: 2017
Journal Articles

Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in Follicular Lymphoma: Results from the Follicular Lymphoma Analysis of Surrogacy Hypothesis (FLASH) Investigation Using Individual Data from 5,453 Patients on 13 Clinical Trials

Carla Casulo, MD, Jennifer Le-Rademacher, PhD, Jesse Dixon, Stat, Gilles Salles, MD, Eva Hoster, Michael Herold, MD, Wolfgang Hiddemann, Catherine Sebban, MD, Robert Marcus, Eva Kimby, Howard Hochster, MD, Umberto Vitolo, MD, Emmanuel Gyan, MDPhD, Fang-Shu Ou, PhD, Tina Nielsen, Kenneth A. Foon, MD, Shi Qiuan, PhD, Christopher Flowers, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 412.
https://doi.org/10.1182/blood.V130.Suppl_1.412.412
Published: 2017
Journal Articles

Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials

Magdalena Klanova, MD, Mikkel Z. Oestergaard, Marek Trněný, MD PhD, Wolfgang Hiddemann, MD PhD, Robert Marcus, Laurie H. Sehn, MDMPH, Umberto Vitolo, MD, Alexandra Bazeos, Valentin Goede, MD, Harald Zeuner, Andrea Knapp, Denis Sahin, Nathalie Danesi, Christopher Bolen, Susan Robson, Jeffrey M. Venstrom, Tina Nielsen, Günter Fingerle-Rowson
Journal: Blood
Blood (2017) 130 (Supplement 1): 727.
https://doi.org/10.1182/blood.V130.Suppl_1.727.727
Published: 2017
Journal Articles

Early Disease Progression Predicts Poorer Survival in Patients with Follicular Lymphoma (FL) in the GALLIUM Study

Aino Launonen, Wolfgang Hiddemann, MD PhD, Ulrich Duenzinger, Günter Fingerle-Rowson, Tina Nielsen, Robert Marcus
Journal: Blood
Blood (2017) 130 (Supplement 1): 1490.
https://doi.org/10.1182/blood.V130.Suppl_1.1490.1490
Published: 2017
Journal Articles

Multiparameter Microscopy Analysis of the Follicular Lymphoma Microenvironment and Normal Germinal Centers: In Vivo evidence That Follicular Helper T Cells Form Synapses with Neoplastic B Cells and Are Associated with Proliferation and Expression of Activation Induced Cytidine Deaminase

William M Townsend, MRCP, Robert Marcus, MB, FRCP, FRCPath, Jon Salisbury, Deborah Yallop, MB, BS, BSc.(hons), MRCP, FRCPath, Piers EM Patten, BSc, MRCP, FRCPath, PhD, Andrea GS Buggins, PhD, Stephen Devereux, MD PhD FRCPath
Journal: Blood
Blood (2014) 124 (21): 144.
https://doi.org/10.1182/blood.V124.21.144.144
Published: 2014
Journal Articles

Obinutuzumab (GA101) Plus CHOP Or FC In Relapsed/Refractory Follicular Lymphoma: Final Data From The Maintenance Phase Of The Phase 1b GAUDI Study (BO21000)

Andrew Davies, MRCP, PhD, John Radford, MD, Guillaume Cartron, MD, PhD, Franck Morschhauser, MD, PhD, Gilles Andre Salles, MD, PhD, Robert Marcus, MB, FRCP, FRCPath, Michael K Wenger, MD, Guiyuan Lei, PhD, Elisabeth Wassner-Fritsch, PharmD, Umberto Vitolo, MD
Journal: Blood
Blood (2013) 122 (21): 1814.
https://doi.org/10.1182/blood.V122.21.1814.1814
Published: 2013
Journal Articles

Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000)

Clinical Trials & Observations
John Radford, Andrew Davies, Guillaume Cartron, Franck Morschhauser, Gilles Salles, Robert Marcus, Michael Wenger, Guiyuan Lei, Elisabeth Wassner-Fritsch, Umberto Vitolo
Journal: Blood
Blood (2013) 122 (7): 1137–1143.
https://doi.org/10.1182/blood-2013-01-481341
Published: 2013